Table 1.
Type of adverse event | Mefloquine group* (n=153) | Chloroquine and proguanil group (n=153) | Doxycycline group (n=153) | Atovaquone and proguanil (n=164) | P value |
---|---|---|---|---|---|
Severity of adverse event: | |||||
Mild† | 135 (88, 83 to 93) | 131 (86, 80 to 91) | 128 (84, 78 to 90) | 134 (82, 75 to 88) | 0.42 |
Moderate‡ | 64 (42, 34 to 50) | 69 (45, 37 to 53) | 51 (33, 26 to 41) | 53 (32, 25 to 40) | 0.048 |
Severe§ | 16 (11, 6 to 15) | 19 (12, 7 to 18) | 9 (6, 2 to 10) | 11 (7, 2 to 11) | 0.14 |
Withdrawals | 6 (4, 1 to 8) | 8 (5, 2 to 9) | 5 (3, 0 to 6) | 3 (2, 0 to 4) | 0.42 |
One participant had a transient ischaemic attack outside follow up; history of two episodes was not declared (mefloquine serum concentrations were negligible).
Trivial but some discomfort noted.
Interferes with daily activity.
Medical advice required.